Ionis Pharmaceuticals (IONS) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Ionis Pharmaceuticals (IONS) over the last 16 years, with Q3 2025 value amounting to -$242.0 million.
- Ionis Pharmaceuticals' Other Gross PP&E Adjustments fell 4717.62% to -$242.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$242.0 million, marking a year-over-year decrease of 4717.62%. This contributed to the annual value of -$52.5 million for FY2024, which is 4173.15% up from last year.
- According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Other Gross PP&E Adjustments is -$242.0 million, which was down 4717.62% from -$163.9 million recorded in Q2 2025.
- Ionis Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $153.1 million for Q4 2021, and its period low was -$242.0 million during Q3 2025.
- For the 5-year period, Ionis Pharmaceuticals' Other Gross PP&E Adjustments averaged around -$130.8 million, with its median value being -$164.4 million (2024).
- As far as peak fluctuations go, Ionis Pharmaceuticals' Other Gross PP&E Adjustments crashed by 17518.28% in 2022, and later soared by 4173.15% in 2024.
- Quarter analysis of 5 years shows Ionis Pharmaceuticals' Other Gross PP&E Adjustments stood at $153.1 million in 2021, then crashed by 175.18% to -$115.1 million in 2022, then rose by 21.68% to -$90.1 million in 2023, then skyrocketed by 41.73% to -$52.5 million in 2024, then plummeted by 360.78% to -$242.0 million in 2025.
- Its Other Gross PP&E Adjustments was -$242.0 million in Q3 2025, compared to -$163.9 million in Q2 2025 and -$159.3 million in Q1 2025.